Who is sponsoring NCT05141396?

NCT05141396 is sponsored by Intermountain Health Care, Inc..

What drugs are being tested in NCT05141396?

Interventions in NCT05141396: Telehealth- enabled support for SAT/SBT adherence, Usual audit and feedback for SAT/SBT adherence.

What condition does NCT05141396 study?

NCT05141396 studies Respiration, Artificial.

Is NCT05141396 still recruiting?

NCT05141396 is currently recruiting now. Last updated 3 July 2023.

Last reviewed 2023-07-03 · How we verify

NCT05141396: TEACH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

Recruiting now NA Last updated 3 July 2023

What this trial tests

NA trial testing Telehealth- enabled support for SAT/SBT adherence in Respiration, Artificial in 13,400 participants. Currently enrolling.

Timeline

1 September 2022

Primary endpoint
31 August 2026

15 October 2026

Quick facts

Lead sponsor	Intermountain Health Care, Inc.
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	13,400
Start date	1 September 2022
Primary completion	31 August 2026
Estimated completion	15 October 2026
Sites	11 locations across United States

Drugs / interventions tested

Telehealth- enabled support for SAT/SBT adherence
Usual audit and feedback for SAT/SBT adherence

Conditions studied

Respiration, Artificial — all drugs for Respiration, Artificial →

Sponsor

Intermountain Health Care, Inc. — full company profile →

Who can join

16 and older, any sex, with Respiration, Artificial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this trial is to evaluate if augmenting a usual audit and feedback implementation approach with telehealth-enabled support improves coordinated spontaneous awakening/breathing trials and patient outcomes for mechanically ventilated patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Awakening and Breathing Coordination: A Mixed-Methods Analysis of Determinants of Implementation.
Olsen GH, Gee PM, Wolfe D, Winberg C, et al · · 2023 · cited 5× · PMID 37413692 · DOI 10.1513/annalsats.202212-1048oc
Implementation of coordinated spontaneous awakening and breathing trials using telehealth-enabled, real-time audit and feedback for clinician adherence (TEACH): a type II hybrid effectiveness-implementation cluster-randomized trial.
Grissom CK, Holubkov R, Carpenter L, Hanna B, et al · · 2023 · cited 4× · PMID 37735443 · DOI 10.1186/s13012-023-01303-1
Normalizing daily awakening and breathing coordination at 15 heterogenous ICUs: a multicenter post-implementation survey.
Knighton AJ, Kean J, Peltan ID, Lisonbee D, et al · · 2025 · PMID 40855450 · DOI 10.1186/s43058-025-00770-5

Verify or expand the search:

Other recruiting trials for Respiration, Artificial

Currently open trials in the same condition.

NCT07098611 — A New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score · recruiting
NCT06293976 — Susceptibility for Entrainment: Role of Ventilator Settings on the Occurrence of Reverse Triggering and Its Physiologica · NA · recruiting
NCT06561295 — Optimal Timing for Spontaneous Breathing Trials · NA · recruiting
NCT05459116 — Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation · NA · recruiting
NCT03439683 — KAP Asynchrony Survey · recruiting

Other Intermountain Health Care, Inc. trials

Trials by the same sponsor.

NCT07334795 — Intermountain Stewardship in Community Outpatient Settings-Resources & Engagement-Pediatrics · active not recruiting
NCT07348289 — PIVO Use for Blood Cultures in the Emergency Department · recruiting
NCT06865781 — Vital Signs Reduction Study · NA · active not recruiting
NCT05936021 — Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease U · NA · unknown
NCT06105242 — Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05141396 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Intermountain Health Care, Inc.
Last refreshed: 3 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05141396.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing